Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
$ACXP
$ADTX
$AGIL
$ALHC
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- OpGen, Inc. (NASDAQ:OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems by Curetis to a strategic partner. OpGen also announced a Preferred Stock Purchase Agreement. It signed an agreement with a certain investor to acquire 1,000 shares priced at $1,000 each, with gross proceeds of $1 million.
- Secoo Holding Limited (NASDAQ:SECO) shares climbed 577.7% to $2.17 after gaining around 12% on Wednesday.
- Versus Systems Inc. (NASDAQ:VS) shares jumped 305% to $0.8728 after gaining around 7% on Wednesday.
- Jaguar Health, Inc. (NASDAQ:JAGX) shares climbed 90.1% to $0.4601, after gaining over 3% on Wednesday.
- Atreca, Inc. (NASDAQ:BCEL) gained 87% to $0.4424.
- ReShape Lifesciences Inc. (NASDAQ:RSLS) shares gained 56.8% to $0.4235. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity."
- BSQUARE Corporation (NASDAQ:BSQR) rose 48.4% to $1.84. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million.
- Edesa Biotech, Inc. (NASDAQ:EDSA) gained 37% to $3.70. Edesa Biotech recently announced a one-for-seven reverse share split.
- LL Flooring Holdings, Inc. (NYSE:LL) jumped 35% to $3.9800. Live Ventures submitted a proposal to acquire LL Flooring for $5.85 per share in cash.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) gained 28.8% to $8.82. Scholar Rock priced upsized $85 million public offering of 12,408,760 common shares at $6.85 per share.
- LogicMark, Inc. (NASDAQ:LGMK) jumped 27% to $1.9824.
- Genetron Holdings Limited (NASDAQ:GTH) gained 26% to $1.1994. Genetron Health entered into definitive merger agreement for going private transaction.
- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) jumped 24% to $4.65. The company recently announced the successful completion and early discontinuation of the Ibezapolstat Phase 2b trial for the treatment of C. difficile infection.
- Blue Star Foods Corp. (NASDAQ:BSFC) gained 23% to $0.2399.
- SeaStar Medical Holding Corporation (NASDAQ:ICU) jumped 22% to $0.6626.
- Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) rose 21.6% to $0.2949.
- OptimizeRx Corporation (NASDAQ:OPRX) gained 17.9% to $8.43 as the company announced preliminary results and disclosed an agreement to acquire Medicx Health for $95 million.
- Shengfeng Development Limited (NASDAQ:SFWL) rose 17.6% to $12.67.
- Aditxt, Inc. (NASDAQ:ADTX) jumped 14.5% to $12.19.
- Biocept, Inc. (NASDAQ:BIOC) gained 13.2% to $1.0550, after falling around 9% on Wednesday.
- Taoping Inc. (NASDAQ:TAOP) shares surged 11.9% to $2.25. Taoping reported a nearly 100% year-over-year surge in its contract revenue value for its cloud-based product, software and advertising businesses in the first nine months of 2023.
- Viasat, Inc. (NASDAQ:VSAT) gained 9.7% to $17.14 as the company issued an interim update on VS-3 F1 satellite status and anticipates positive free cash flow earlier than planned.
- Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) climbed 8.5% to $24.74. Cerevel Therapeutics reported pricing of underwritten public offering of 19,728,189 shares of its common stock at $22.81 per share.
- Fastenal Company (NASDAQ:FAST) gained 7% to $59.89 after the company reported mixed third-quarter financial results.
Losers
- RVL Pharmaceuticals plc (NASDAQ:RVLP) shares fell 52.4% to $0.0750. RVL Pharmaceuticals said certain of its U.S. operating subsidiaries, have agreed with their secured lenders, Athyrium Capital Management, and other key stakeholders, to effectuate a change of control transaction through prepackaged bankruptcy cases.
- Tempest Therapeutics, Inc. (NASDAQ:TPST) fell 50.2% to $4.8670. Tempest Therapeutics shares jumped 2,879% on Wednesday, the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study.
- T2 Biosystems, Inc. (NASDAQ:TTOO) fell 39.8% to $0.1865. T2 Biosystems announced a 1-for-100 reverse stock split, effective today.
- Phio Pharmaceuticals Corp. (NASDAQ:PHIO) fell 38% to $1.61. Phio Pharmaceuticals shares surged 91% on Wednesday after the company announced the poster presentation of two key preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- Soluna Holdings, Inc. (NASDAQ:SLNH) fell 35.7% to $0.1776. Soluna announced a 1-for-25 reverse stock split.
- Agape ATP Corporation (NASDAQ:ATPC) shares dipped 33% to $1.22, after falling 46% on Wednesday.
- Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares fell 26.7% to $0.9890 after jumping around 52% on Wednesday.
- Clearmind Medicine Inc. (NASDAQ:CMND) fell 23% to $0.1741, after surging 50% on Wednesday.
- ShiftPixy, Inc. (NASDAQ:PIXY) declined 21.1% to $0.8124. The company last week announced a $2.5 million registered direct offering and concurrent private placement.
- Sidus Space, Inc. (NASDAQ:SIDU) fell 20.6% to $0.1030. Sidus Space announced a $2 million registered direct offering and concurrent private placement.
- GlucoTrack, Inc. (NASDAQ:GCTK) dipped 20.6% to $0.2400 as the company announced preclinical testing with implantable continuous glucose monitor.
- InMode Ltd. (NASDAQ:INMD) fell 20.2% to $22.35 after the company issued third-quarter guidance below estimates and lowered full-year 2023 revenue guidance.
- SuperCom Ltd. (NASDAQ:SPCB) declined 19.5% to $0.4401.
- CVRx, Inc. (NASDAQ:CVRX) fell 18.4% to $10.36.
- AgileThought, Inc. (NASDAQ:AGIL) fell 15.7% to $0.1535, after gaining 23% on Wednesday.
- NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) fell 15% to $1.1050. NGM Bio announced oral plenary presentation of data from Phase 2b ALPINE 4 trial of aldafermin in compensated cirrhosis (F4) due to NASH at upcoming AASLD The Liver Meeting.
- Tango Therapeutics, Inc. (NASDAQ:TNGX) declined 12.4% to $7.75.
- Alignment Healthcare, Inc. (NASDAQ:ALHC) fell 11.8% to $6.51.
- Alpha Metallurgical Resources, Inc. (NYSE:AMR) declined 10.5% to $223.90. Alpha Metallurgical Resources disclosed preliminary sales volumes and realizations for the third quarter & lowered FY23 metallurgical coal shipment guidance to 14.8 million-15.2 million tons from 15.0 million-16.0 million tons.
- Carvana Co. (NYSE:CVNA) declined 10% to $34.08. Exane BNP Paribas downgraded Carvana from Outperform to Neutral.
- National CineMedia, Inc. (NASDAQ:NCMI) fell 9.4% to $3.63.
- The Beauty Health Company (NASDAQ:SKIN) fell 8.8% to $5.26.
- Luxfer Holdings PLC (NYSE:LXFR) fell 8.5% to $10.64.
- Commercial Metals Company (NYSE:CMC) fell 8.1% to $44.44 after the company reported mixed fourth-quarter financial results.
- Hormel Foods Corporation (NYSE:HRL) declined 8% to $33.35.
- Infosys Limited (NYSE:INFY) fell 6.3% to $16.50. Infosys reported second-quarter revenue growth of 3.6% year-on-year to $4.72 billion, beating the consensus of $4.61 billion.
Now Read This: SMART Global Holdings Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call